Walgreens Eye Drops Pulled Over Sterility Fears

Photo: Shutterstock

More than 500,000 bottles of Walgreens-branded eye drops are off store shelves because the maker could not prove they were germ-free.

Quick Take

Sterling Pharmaceutical Services recalled nearly 750,000 eye-care bottles starting August 20, citing a “lack of assurance of sterility.”
More than 500,000 of those bottles carry the Walgreens brand name.
The Food and Drug Administration (FDA) later classified the recall as Class II, meaning use could cause temporary or treatable health problems.
No injuries have been tied to these specific bottles, but the recall follows a pattern of similar eye-drop sterility failures in recent years.

What Triggered The Recall And Who Is Involved

Sterling Pharmaceutical Services LLC, based in Dupo, Illinois, started pulling its eye-care products on August 20 after it could not confirm the drops met sterility standards. The company did not report finding actual contamination. Instead, it said its own testing process failed to prove the products were clean enough for safe use in the eye, which triggered the voluntary pullback.

The FDA later stepped in and upgraded the recall to a Class II designation on September 21. That label means the agency believes using the affected drops could lead to short-term or reversible health issues, not permanent injury or death. The recall ultimately covered 747,844 units across nine different eye drop and ointment products sold under several store brands.

Why Sterility Rules Are So Strict For Eye Products

Eye drops face a tougher bar than most over-the-counter medicine. Anything placed directly in the eye must be sterile, because the eye has almost no natural defense against bacteria or fungus once a seal is broken. The FDA has long warned that non-sterile products meant to be sterile can cause serious, even life-threatening infections.

That is why “lack of assurance of sterility” counts as a real safety trigger on its own, even without a confirmed case of contamination. One clinical professor from the University of California, Davis explained the distinction plainly: manufacturers sometimes cannot say whether a product was contaminated, only that they cannot prove it was not. That uncertainty alone is enough to pull products from shelves.

How This Recall Fits A Bigger Pattern

This is not an isolated incident. A separate 2026 recall from K.C. Pharmaceuticals pulled more than 3.1 million bottles of eye drops sold at Walgreens, CVS, Kroger, Rite Aid, and other major retailers for the same stated reason. Both recalls trace back to manufacturers failing to verify sterility, not to a single dramatic outbreak of illness.

A review of FDA recall data found that “lack of assurance of sterility” is actually the most common reason sterile drug products get pulled, outranking confirmed non-sterile findings and general manufacturing slip-ups combined. Eye drop recalls tied to contamination or unsanitary manufacturing conditions have also hit dozens of products since 2023, according to health researchers tracking the trend.

What Shoppers Should Actually Do Right Now

Consumers who bought Walgreens-brand lubricant eye drops should check the lot numbers listed in the FDA’s recall notice against the bottles in their medicine cabinet. The safest move is simple: stop using any matching product immediately and either toss it or return it to the store for a refund, rather than waiting to see if symptoms appear.

Anyone who already used the recalled drops and notices eye redness, pain, discharge, or vision changes should contact a doctor right away. So far, no injuries have been formally linked to this particular Sterling Pharmaceutical recall, but given how fast eye infections can turn serious, it pays to treat any symptom as worth a same-day call to an eye doctor rather than a wait-and-see approach.

The Bottom Line For Consumers Who Trust Store Brands

This recall is a reminder that a store’s name on the label does not guarantee a different manufacturing process than any other brand. Walgreens did not make these drops; it sold a product manufactured and tested by an outside company, and that company is the one accountable for the sterility failure. That distinction matters when deciding how much trust to place in branding versus the actual maker behind the product.

Regulators acted here before any confirmed injury, which is exactly how a precautionary system is supposed to work. Conservative-minded consumers who favor accountability and swift corrective action should see this as the system functioning as intended: a manufacturer flagged its own uncertainty, and the FDA escalated oversight once it reviewed the facts.

🚨 RECALL: More than 500,000 Walgreens-branded eye-drop products are being recalled over concerns about sterility. Check your eye drops and compare them with the recall details before using them.

Read more: https://t.co/V3hQiPWPZq #PoisonHelp 1-800-222-1222.

— FL Poison Control (@FloridaPoison) October 5, 2026

Checking your bathroom shelf for the affected lot numbers takes two minutes and costs nothing. Given how easily eye infections can escalate, that small effort is a reasonable trade for peace of mind.